Among the 284/451 ( 63 % ) patients who had their QE on AT , the 2-year primary end point rates were 15.6 % for those randomized to AMM ( n = 140 ) and 21.6 % for PTAS ( n = 144 ; P = 0.043 , log-rank test ) .